Barbounis V, Efremidis A
2nd Department of Medical Oncology, St. Savvas Regional Anticancer Hospital, Athens, Greece.
Anticancer Res. 1996 Jan-Feb;16(1):545-7.
Castleman's disease is a rare benign condition of uncertain etiology, with several forms. It is postulated that a dysregulated inflammatory response may play a role in the pathogenesis of this disease. We report on a case of Castleman's disease treated with the histamine receptor-2 antagonist cimetidine with favourable response, suggesting that cimetidine may be helpful in the treatment of this disease.
卡斯尔曼病是一种病因不明的罕见良性疾病,有多种类型。据推测,炎症反应失调可能在该疾病的发病机制中起作用。我们报告了一例用组胺H2受体拮抗剂西咪替丁治疗且反应良好的卡斯尔曼病病例,提示西咪替丁可能有助于治疗该疾病。